Given the central role of HIF‐2α in mediating proliferation arrest under iron‐deficient conditions, we tested whether transient pharmacological inhibition of HIF‐2α could improve muscle regeneration under iron deficiency. Here, EPAS1 is linked to Iron deficiency anemia.